Avatrombopag
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Avatrombopag for Chemotherapy-induced Thrombocytopenia (NCT05218226) | Institute of Hematology & Blood Diseases Hospital, China | 2022-02-10 |
| Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia (NCT04896528) | Peking Union Medical College Hospital | 2021-06-06 |
Track Avatrombopag automatically
Every clearance here is in the API, with alerts when new ones post.